The Fox Tales

Main Menu

  • Home
  • Novel update
  • Novel books
  • Novel story
  • Novel list

The Fox Tales

Header Banner

The Fox Tales

  • Home
  • Novel update
  • Novel books
  • Novel story
  • Novel list
Novel update
Home›Novel update›SIGA Technologies will organize a commercial update call in November

SIGA Technologies will organize a commercial update call in November

By Jack N. Hernandez
October 28, 2021
0
0


NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) – SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call for provide an update at 4:30 p.m. ET on Thursday, November 4e, 2021. Dr Phil Gomez, Managing Director, Daniel Luckshire, CFO and Dennis Hruby, Scientific Director, will participate in the call.

A live webcast of the call will also be available on the Company’s website at www.siga.com under the “Events and Presentations” tab in the Investor Relations section, or by clicking here. Please log in approximately 5-10 minutes before the scheduled start time.

Participants can access the call by dialing 1-877-425-9470 for national calls or 1-201-389-0878 for international calls.

A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using conference ID: 13722063. Archived webcast will be available in the Events and Presentations section of the Company’s website.

ABOUT SIGA TECHNOLOGIES, INC. and TPOXX®

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the food safety market. Health security includes countermeasures to biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies against emerging infectious diseases and health preparedness. Our flagship product is TPOXX®, also known as tecovirimat and ST-246®, an antiviral drug administered by mouth and IV for the treatment of human smallpox caused by variola virus. TPOXX® is a new small molecule drug and the US government maintains a stockpile of TPOXX® for the treatment of smallpox. Over the past decade, the U.S. government has purchased or currently has orders for approximately $ 705 million from TPOXX® for national preparation. The oral formulation of TPOXX® was approved by the FDA for the treatment of smallpox in 2018. The full label is here: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fce826ab-4d6a-4139-a2ee-a304a913a253.

For more information on SIGA, please visit www.siga.com.

ABOUT LA VAROCHEI

Smallpox is a contagious, disfiguring and often fatal disease that has affected humans for thousands of years. Naturally occurring smallpox was eradicated worldwide in 1980, the result of an unprecedented global vaccination campaign. Smallpox virus samples were kept for research. This has led to fears that smallpox could one day be used as a biological warfare agent. A vaccine can prevent smallpox, but the risk of side effects from the current vaccine is too high to justify routine immunization of people at low risk of exposure to the smallpox virus.

FORWARD-LOOKING STATEMENTS

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are subject to various known and unknown risks and uncertainties, and SIGA cautions you that any forward-looking information provided by or on behalf of SIGA is not a guarantee of future performance. More detailed information about SIGA and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements contained in this press release, are set out in the documents filed by SIGA with the Securities and Exchange Commission, including the SIGA’s annual report on Form 10. -K for the year ended December 31, 2020, and in other documents that SIGA has filed with the SEC. SIGA urges investors and security holders to read these documents for free on the SEC’s website at http://www.sec.gov. Interested parties can also obtain these documents free of charge from SIGA. Forward-looking statements are only current as of the date on which such statements were made, and except for our continued obligations under the federal securities laws of the United States of America, we do not undertake not publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

The information in this press release does not necessarily reflect the position or policy of the government and no official endorsement should be inferred.

Investor contacts:
Laine Yonker, Edison Group
[email protected]

Michael Crawford, Edison Group
[email protected]

______________________
I http://www.mayoclinic.org/diseases-conditions/smallpox/basics/definition/con-20022769


Related posts:

  1. Takeda Pharmaceutical provides update on the status of its own share acquisition
  2. Recap and update positive data from three presentations
  3. Appili Therapeutics Announces Update to Funding Agreement with The Lind Partners
  4. Veru to Present Company Update at HC Wainwright BioConnect Conference January 10-13, 2022
Tagspress releaseunited states

Categories

  • Novel books
  • Novel list
  • Novel story
  • Novel update

Recent Posts

  • Three books about Stalin that shed light on Russian history
  • Rakovina Therapeutics Inc. Announces First Quarter 2022 Financial Results and Provides Business Update
  • Best Stan shows and movies June 2022: Full list of upcoming Stan shows in June, including All I Know About Love, P-Valley, Queer as Folk (2022) and Becoming Elizabeth
  • The Unexpected Crazy True Story of How Natasha Lance Rogoff Created Sesame Street in Russia
  • Fiction and non-fiction books that navigate the roller coaster of grief

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • May 2021
  • April 2021
  • February 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • March 2020
  • February 2020
  • September 2019
  • June 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • May 2018
  • November 2016
  • September 2016
  • May 2016
  • December 2015
  • September 2015
  • December 2014
  • July 2014
  • May 2014
  • March 2014
  • July 2013
  • Privacy Policy
  • Terms and Conditions